Alfons J.M. van den Eertwegh
Amsterdam Neuroscience(NL)Amsterdam University Medical Centers(NL)Amsterdam University Medical Centers(NL)Cancer Center Amsterdam(NL)Cancer Center AmsterdamVrije Universiteit Amsterdam(NL)University of Amsterdam(NL)Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)Amsterdam UMC Location VUmc(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, CAR-T cell therapy research, Prostate Cancer Treatment and Research
Most-Cited Works
- → Improved Survival with Ipilimumab in Patients with Metastatic Melanoma(2010)15,037 cited
- → Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial(2014)1,480 cited
- A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.(2002)
- → Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma(2022)495 cited
- → Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial(2021)373 cited
- → Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage(2001)270 cited